Nephros Inc (NEPH) stock
NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3023% below fair value
$2.89−0.01 (-0.34%)
Close on Nov 18, 2026Market cap $31.39MP/E 18.1Yield –
Nephros shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Nephros's shares outstanding was 11M at Jun 30, 2026. For fiscal 2025 it was 11M, up 3.5% from the year before. Over ten years it grew 11.0% a year on average. The highest annual figure on record is 11M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11M | +3.5% |
| FY2024 | Dec 31, 2024 | 11M | +2.1% |
| FY2023 | Dec 31, 2023 | 10M | +0.9% |
| FY2022 | Dec 31, 2022 | 10M | +2.8% |
| FY2021 | Dec 31, 2021 | 10M | +10.3% |
| FY2020 | Dec 31, 2020 | 9M | +20.4% |
| FY2019 | Dec 31, 2019 | 8M | +10.2% |
| FY2018 | Dec 31, 2018 | 7M | +16.4% |
| FY2017 | Dec 31, 2017 | 6M | +9.0% |
| FY2016 | Dec 31, 2016 | 5M | +39.7% |
| FY2015 | Dec 31, 2015 | 4M | +46.0% |
| FY2014 | Dec 31, 2014 | 3M | +14.7% |
| FY2013 | Dec 31, 2013 | 2M | +85.0% |
| FY2012 | Dec 31, 2012 | 1M | +29.8% |
| FY2011 | Dec 31, 2011 | 1M | +314.2% |
| FY2010 | Dec 31, 2010 | 0M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 11M | +2.8% |
| Q1 FY2026 | Mar 31, 2026 | 11M | +3.5% |
| Q4 FY2025 | Dec 31, 2025 | 11M | +4.4% |
| Q3 FY2025 | Sep 30, 2025 | 11M | +4.3% |
| Q2 FY2025 | Jun 30, 2025 | 11M | +2.9% |
| Q1 FY2025 | Mar 31, 2025 | 11M | +1.1% |
| Q4 FY2024 | Dec 31, 2024 | 11M | +3.5% |
| Q3 FY2024 | Sep 30, 2024 | 11M | +1.1% |
| Q2 FY2024 | Jun 30, 2024 | 11M | +2.1% |
| Q1 FY2024 | Mar 31, 2024 | 11M | +2.0% |
| Q4 FY2023 | Dec 31, 2023 | 10M | +1.3% |
| Q3 FY2023 | Sep 30, 2023 | 10M | +1.5% |
| Q2 FY2023 | Jun 30, 2023 | 10M | -0.0% |
| Q1 FY2023 | Mar 31, 2023 | 10M | +0.8% |
| Q4 FY2022 | Dec 31, 2022 | 10M | +1.5% |
| Q3 FY2022 | Sep 30, 2022 | 10M | +2.6% |
| Q2 FY2022 | Jun 30, 2022 | 10M | +3.6% |
| Q1 FY2022 | Mar 31, 2022 | 10M | +3.3% |
| Q4 FY2021 | Dec 31, 2021 | 10M | +5.2% |
| Q3 FY2021 | Sep 30, 2021 | 10M | +11.1% |
| Q2 FY2021 | Jun 30, 2021 | 10M | +10.6% |
| Q1 FY2021 | Mar 31, 2021 | 10M | +15.0% |
| Q4 FY2020 | Dec 31, 2020 | 10M | +22.1% |
| Q3 FY2020 | Sep 30, 2020 | 9M | +17.4% |
| Q2 FY2020 | Jun 30, 2020 | 9M | +21.6% |
| Q1 FY2020 | Mar 31, 2020 | 9M | +20.5% |
| Q4 FY2019 | Dec 31, 2019 | 8M | +11.4% |
| Q3 FY2019 | Sep 30, 2019 | 8M | +8.0% |
| Q2 FY2019 | Jun 30, 2019 | 7M | +5.1% |
| Q1 FY2019 | Mar 31, 2019 | 7M | +15.5% |
| Q4 FY2018 | Dec 31, 2018 | 7M | +18.2% |
| Q3 FY2018 | Sep 30, 2018 | 7M | +18.5% |
| Q2 FY2018 | Jun 30, 2018 | 7M | +18.0% |
| Q1 FY2018 | Mar 31, 2018 | 6M | +12.0% |
| Q4 FY2017 | Dec 31, 2017 | 6M | +11.3% |
| Q3 FY2017 | Sep 30, 2017 | 6M | +11.0% |
| Q2 FY2017 | Jun 30, 2017 | 6M | – |
| Q1 FY2017 | Mar 31, 2017 | 6M | – |
| Q4 FY2016 | Dec 31, 2016 | 5M | – |
| Q3 FY2016 | Sep 30, 2016 | 5M | – |
See a number that looks wrong?